{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:31:30Z","timestamp":1793723490208,"version":"4.6.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.biopsych.2019.07.027","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T16:12:06Z","timestamp":1565107926000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-1634","authenticated-orcid":false,"given":"Lola","family":"Welsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4804-6724","authenticated-orcid":false,"given":"Julie","family":"Bailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Darcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8809-8334","authenticated-orcid":false,"given":"Brigitte Lina","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.07.027_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.07.027_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13011-017-0120-7","article-title":"Chronic pain and opioid misuse: A review of reviews","volume":"12","author":"Voon","year":"2017","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.biopsych.2019.07.027_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/pmt-2018-0070","article-title":"Considerations in addressing the opioid epidemic and chronic pain within the USA","volume":"9","author":"Marshall","year":"2019","journal-title":"Pain Manag"},{"key":"10.1016\/j.biopsych.2019.07.027_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41582-019-0146-8","article-title":"The role of neurologists in tackling the opioid epidemic","volume":"15","author":"Volkow","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: A neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2019.07.027_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.pnpbp.2015.10.009","article-title":"Medications between psychiatric and addictive disorders","volume":"65","author":"Lalanne","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11920-014-0544-y","article-title":"Anxiety and substance use disorders: Co-occurrence and clinical issues","volume":"17","author":"Vorspan","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2019.07.027_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2017.19.3\/gkoob","article-title":"Individual differences in the neuropsychopathology of addiction","volume":"19","author":"George","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-013-1221-7","article-title":"Neuropathology of substance use disorders","volume":"127","author":"Cadet","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2990.2010.01131.x","article-title":"Review: The neuropathology of drug abuse","volume":"37","author":"Buttner","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib12","first-page":"S57","article-title":"The impact of street drugs on trauma care","volume":"59","author":"Lucas","year":"2005","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.biopsych.2019.07.027_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archpsyc.1994.03950060058006","article-title":"Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts","volume":"51","author":"Escriba","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib14","doi-asserted-by":"crossref","first-page":"301A","DOI":"10.1111\/j.1530-0277.1996.tb01797.x","article-title":"Alteration of glutamyltranspeptidase binding proteins in postmortem brains of heroin addicts","volume":"20","author":"Hashimoto","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0379-0738(00)00204-8","article-title":"The neuropathology of heroin abuse","volume":"113","author":"Buttner","year":"2000","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.biopsych.2019.07.027_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11065-007-9041-y","article-title":"Neuropsychological consequences of opiate use","volume":"17","author":"Gruber","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.biopsych.2019.07.027_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fpsyt.2016.00080","article-title":"Overlapping mechanisms of stress-induced relapse to opioid use disorder and chronic pain: Clinical implications","volume":"7","author":"Ghitza","year":"2016","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1526-4637.2010.00881.x","article-title":"Opioids, pain, the brain, and hyperkatifeia: A framework for the rational use of opioids for pain","volume":"11","author":"Shurman","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.biopsych.2019.07.027_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.mcna.2018.02.012","article-title":"Sleep management among patients with substance use disorders","volume":"102","author":"Chakravorty","year":"2018","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.biopsych.2019.07.027_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1521-0391.2013.12025.x","article-title":"Acute effects of heroin on emotions in heroin-dependent patients","volume":"22","author":"Blum","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2019.07.027_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jbtep.2011.10.004","article-title":"Biased attention towards negative schematic expression in abstinent heroin abusers","volume":"43","author":"Zhou","year":"2012","journal-title":"J\u00a0Behav Ther Exp Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.pnpbp.2013.10.011","article-title":"Dysregulated responses to emotions among abstinent heroin users: Correlation with childhood neglect and addiction severity","volume":"48","author":"Gerra","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41386-018-0232-4","article-title":"Can neuroimaging help combat the opioid epidemic? A systematic review of clinical and pharmacological challenge fMRI studies with recommendations for future research","volume":"44","author":"Moningka","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fpsyt.2019.00117","article-title":"Forging neuroimaging targets for recovery in opioid use disorder","volume":"10","author":"Stewart","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fnhum.2017.00169","article-title":"Resting-state neuroimaging and neuropsychological findings in opioid use disorder during abstinence: A review","volume":"11","author":"Ieong","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuroimage.2015.04.060","article-title":"Nature of functional links in valuation networks differentiates impulsive behaviors between abstinent heroin-dependent subjects and nondrug-using subjects","volume":"115","author":"Zhai","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2019.07.027_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2009.05.038","article-title":"Dysfunctional connectivity patterns in chronic heroin users: An fMRI study","volume":"460","author":"Liu","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.07.027_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbr.2010.09.004","article-title":"Identification of hyperactive intrinsic amygdala network connectivity associated with impulsivity in abstinent heroin addicts","volume":"216","author":"Xie","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2010.03.033","article-title":"Combining spatial and temporal information to explore resting-state networks changes in abstinent heroin-dependent individuals","volume":"475","author":"Yuan","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.07.027_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/adb.12228","article-title":"Abnormal gray matter volume and resting-state functional connectivity in former heroin-dependent individuals abstinent for multiple years","volume":"21","author":"Wang","year":"2016","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jnr.23608","article-title":"Abnormal resting-state functional connectivity of the nucleus accumbens in multi-year abstinent heroin addicts","volume":"93","author":"Zou","year":"2015","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","article-title":"Opioid receptors: Drivers to addiction?","volume":"19","author":"Darcq","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2013.08.028","article-title":"15 years of genetic approaches in\u00a0vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse","volume":"76 Pt B","author":"Charbogne","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tins.2015.01.002","article-title":"Understanding opioid reward","volume":"38","author":"Fields","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/383819a0","article-title":"Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene","volume":"383","author":"Matthes","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.07.027_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of mu-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2019.07.027_bib37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.tips.2016.08.002","article-title":"Allostatic mechanisms of opioid tolerance beyond desensitization and downregulation","volume":"37","author":"Cahill","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib38","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8369.1","article-title":"Neurobiology of opioid dependence in creating addiction vulnerability","volume":"5","author":"Evans","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2019.07.027_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.biopsych.2019.07.027_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1037\/0735-7044.109.1.91","article-title":"Neurobiology of withdrawal motivation: Evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal","volume":"109","author":"Bechara","year":"1995","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2004.06.006","article-title":"Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence","volume":"79","author":"Liu","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2019.07.027_bib43","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/npp.2009.56","article-title":"Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure","volume":"34","author":"Rothwell","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00213-011-2425-y","article-title":"Protracted manifestations of acute dependence after a single morphine exposure","volume":"219","author":"Rothwell","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.07.027_bib45","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41386-018-0234-2","article-title":"Relapse to opioid seeking in rat models: Behavior, pharmacology and circuits","volume":"44","author":"Reiner","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130100793","article-title":"Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test","volume":"157","author":"Anraku","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.07.027_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1369-1600.2007.00068.x","article-title":"Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio","volume":"12","author":"Zhang","year":"2007","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib48","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1037\/0735-7044.119.4.1034","article-title":"Increased vulnerability to stress following opiate exposures: Behavioral and autonomic correlates","volume":"119","author":"Blatchford","year":"2005","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/npp.2013.285","article-title":"The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice","volume":"39","author":"Zanos","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lfs.2008.11.002","article-title":"Different affective response to opioid withdrawal in adolescent and adult mice","volume":"84","author":"Hodgson","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.npp.1300122","article-title":"Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing","volume":"28","author":"Harris","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.npp.1300037","article-title":"Enhanced morphine preference following prolonged abstinence: Association with increased Fos expression in the extended amygdala","volume":"28","author":"Harris","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib53","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopsych.2010.08.021","article-title":"Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine","volume":"69","author":"Goeldner","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib54","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1038\/npp.2014.126","article-title":"Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence","volume":"39","author":"Lutz","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/adb.12405","article-title":"Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol","volume":"22","author":"Becker","year":"2017","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroscience.2018.10.032","article-title":"Wnt7a in mouse insular cortex contributes to anxiety-like behavior during protracted abstinence from morphine","volume":"394","author":"Ma","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2019.07.027_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yfrne.2014.01.001","article-title":"Corticotropin releasing factor: A key role in the neurobiology of addiction","volume":"35","author":"Zorrilla","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib58","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/nn.3872","article-title":"VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation","volume":"17","author":"Grieder","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib59","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41467-019-09183-0","article-title":"Inactivation of a CRF-dependent amygdalofugal pathway reverses addiction-like behaviors in alcohol-dependent rats","volume":"10","author":"de Guglielmo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.07.027_bib60","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1037\/0735-7044.120.5.1169","article-title":"Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures","volume":"120","author":"Blatchford","year":"2006","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw011","article-title":"Emotional impairment and persistent upregulation of mGlu5 receptor following morphine abstinence: Implications of an mGlu5-MOPr Interaction","volume":"19","author":"Zanos","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0893-133X(00)00184-6","article-title":"Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal","volume":"24","author":"Harris","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib63","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/adb.12392","article-title":"Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence","volume":"22","author":"Lalanne","year":"2017","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13041-017-0306-y","article-title":"The role of 5-HT receptors in depression","volume":"10","author":"Yohn","year":"2017","journal-title":"Mol Brain"},{"key":"10.1016\/j.biopsych.2019.07.027_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.neuro.051508.135607","article-title":"Serotonin in affective control","volume":"32","author":"Dayan","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/npp.2015.258","article-title":"Dynorphin, dysphoria, and dependence: The stress of addiction","volume":"41","author":"Chavkin","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuropharm.2015.09.031","article-title":"Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice","volume":"101","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2015.09.013","article-title":"Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice","volume":"607","author":"Wu","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2019.07.027_bib70","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s12035-018-1318-z","article-title":"Molecular adaptations in the rat dorsal striatum and hippocampus following abstinence-induced incubation of drug seeking after escalated oxycodone self-administration","volume":"56","author":"Blackwood","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib71","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1111\/j.1460-9568.2008.06273.x","article-title":"Mu-opioid receptor activation induces transcriptional plasticity in the central extended amygdala","volume":"27","author":"Befort","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2011.00365.x","article-title":"Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network","volume":"17","author":"Le Merrer","year":"2012","journal-title":"Addict Biol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00429-014-0717-9","article-title":"A\u00a0mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks","volume":"220","author":"Erbs","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.biopsych.2019.07.027_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.isci.2019.03.011","article-title":"Biased signaling of the mu opioid receptor revealed in native neurons","volume":"14","author":"Ehrlich","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.biopsych.2019.07.027_bib75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-neuro-080317-061522","article-title":"Endogenous and exogenous opioids in pain","volume":"41","author":"Corder","year":"2018","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib76","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2019.07.027_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: Distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-neuro-070815-014106","article-title":"Reward and aversion","volume":"39","author":"Hu","year":"2016","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib79","doi-asserted-by":"crossref","first-page":"20140210","DOI":"10.1098\/rstb.2014.0210","article-title":"Contemporary approaches to neural circuit manipulation and mapping: Focus on reward and addiction","volume":"370","author":"Saunders","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nn.3622","article-title":"Targeted expression of mu-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward","volume":"17","author":"Cui","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib81","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.biopsych.2016.12.022","article-title":"Mu opioid receptors in gamma-aminobutyric acidergic forebrain neurons moderate motivation for heroin and palatable food","volume":"81","author":"Charbogne","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib82","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2019.07.027_bib83","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.07.027_bib84","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1460-9568.2004.03665.x","article-title":"GABAA receptors signal bidirectional reward transmission from the ventral tegmental area to the tegmental pedunculopontine nucleus as a function of opiate state","volume":"20","author":"Laviolette","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2003.11.011","article-title":"Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation","volume":"124","author":"Narayanan","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2019.07.027_bib86","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuroscience.2014.07.053","article-title":"Expression of mu opioid receptor in dorsal diencephalic conduction system: New insights for the medial habenula","volume":"277","author":"Gardon","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2019.07.027_bib87","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrn2866","article-title":"The habenula: From stress evasion to value-based decision-making","volume":"11","author":"Hikosaka","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2016.06.003","article-title":"Translating the habenula-from rodents to humans","volume":"81","author":"Boulos","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib89","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.biopsych.2016.12.004","article-title":"The habenula: Darkness, disappointment, and depression","volume":"81","author":"Kaye","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neubiorev.2018.06.018","article-title":"From controlled to compulsive drug-taking: The role of the habenula in addiction","volume":"106","author":"Mathis","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2019.07.027_bib91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fpsyt.2019.00100","article-title":"The role of the medial habenula cholinergic system in addiction and emotion-associated behaviors","volume":"10","author":"Lee","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fnsyn.2018.00046","article-title":"Dysregulation of the lateral habenula in major depressive disorder","volume":"10","author":"Browne","year":"2018","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cne.20410","article-title":"Dendritic morphology, local circuitry, and intrinsic electrophysiology of neurons in the rat medial and lateral habenular nuclei of the epithalamus","volume":"483","author":"Kim","year":"2005","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.biopsych.2019.07.027_bib94","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0306-4522(01)00333-5","article-title":"Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice","volume":"106","author":"Skoubis","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2019.07.027_bib95","article-title":"Mu opioid receptors in the medial habenula contribute to naloxone aversion","author":"Boulos","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2019.07.027_bib96","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1523\/JNEUROSCI.5032-05.2006","article-title":"No effect of morphine on ventral tegmental dopamine neurons during withdrawal","volume":"26","author":"Georges","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib97","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1523\/JNEUROSCI.0715-15.2015","article-title":"Persistent adaptations in afferents to ventral tegmental dopamine neurons after opiate withdrawal","volume":"35","author":"Kaufling","year":"2015","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature16954","article-title":"A\u00a0thalamic input to the nucleus accumbens mediates opiate dependence","volume":"530","author":"Zhu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.07.027_bib99","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41593-019-0421-4","article-title":"Morphine withdrawal recruits lateral habenula cytokine signaling to reduce synaptic excitation and sociability","volume":"22","author":"Valentinova","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopsych.2015.01.004","article-title":"How preclinical models evolved to resemble the diagnostic criteria of drug addiction","volume":"79","author":"Belin-Rauscent","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.07.027_bib101","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.1601640113","article-title":"Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome","volume":"113","author":"Mechling","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.07.027_bib102","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2741\/e816","article-title":"Genetic addiction risk score (GARS), a predictor of vulnerability to opioid dependence","volume":"10","author":"Blum","year":"2018","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.biopsych.2019.07.027_bib103","first-page":"452","article-title":"Multi-variant genetic panel for genetic risk of opioid addiction","volume":"47","author":"Donaldson","year":"2017","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.13735","article-title":"OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients","author":"Muriel","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrn.2017.113","article-title":"Rehabilitating the addicted brain with transcranial magnetic stimulation","volume":"18","author":"Diana","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.07.027_bib106","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbr.2006.10.012","article-title":"Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal","volume":"176","author":"Harris","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2019.07.027_bib107","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.euroneuro.2011.02.002","article-title":"Sequential and opposing alterations of 5-HT(1A) receptor function during withdrawal from chronic morphine","volume":"21","author":"Lutz","year":"2011","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319315628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322319315628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:03:39Z","timestamp":1757775819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322319315628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0006322319315628"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.07.027","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}